Sarilumab (Kevzara) for polymyalgia rheumatica.

Source :: The Medical letter on drugs and therapeutics [Med Lett Drugs Ther] 2024 May 13; Vol. 66 (1702), pp. 77-78.
Publication Year :: 2024

Subjects :: Humans
Treatment Outcome
Antibodies, Monoclonal therapeutic use
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal administration & dosage
Polymyalgia Rheumatica drug therapy
Polymyalgia Rheumatica diagnosis
Antibodies, Monoclonal, Humanized adverse effects
Antibodies, Monoclonal, Humanized therapeutic use

Full Text Access

Tools